Your browser doesn't support javascript.
loading
Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients--Report of a Phase I/IIa Clinical Trial.
Legat, Amandine; Maby-El Hajjami, Hélène; Baumgaertner, Petra; Cagnon, Laurène; Abed Maillard, Samia; Geldhof, Christine; Iancu, Emanuela M; Lebon, Luc; Guillaume, Philippe; Dojcinovic, Danijel; Michielin, Olivier; Romano, Emanuela; Berthod, Grégoire; Rimoldi, Donata; Triebel, Frédéric; Luescher, Immanuel; Rufer, Nathalie; Speiser, Daniel E.
Afiliação
  • Legat A; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.
  • Maby-El Hajjami H; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.
  • Baumgaertner P; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.
  • Cagnon L; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerland.
  • Abed Maillard S; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerland.
  • Geldhof C; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.
  • Iancu EM; Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerland.
  • Lebon L; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.
  • Guillaume P; TCMetrix, Epalinges, Switzerland.
  • Dojcinovic D; TCMetrix, Epalinges, Switzerland.
  • Michielin O; Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerland.
  • Romano E; Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerland.
  • Berthod G; Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerland.
  • Rimoldi D; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.
  • Triebel F; Immutep, SA, Orsay, France.
  • Luescher I; TCMetrix, Epalinges, Switzerland.
  • Rufer N; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerland.
  • Speiser DE; Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. Department of Oncology, Lausanne University Hospital Center (CHUV) and University of Lausanne, Lausanne, Switzerland. doc@dspeiser.ch.
Clin Cancer Res ; 22(6): 1330-40, 2016 Mar 15.
Article em En | MEDLINE | ID: mdl-26500235
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Linfócitos T CD4-Positivos / Antígenos CD / Linfócitos T CD8-Positivos / Vacinas Anticâncer / Melanoma Limite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Linfócitos T CD4-Positivos / Antígenos CD / Linfócitos T CD8-Positivos / Vacinas Anticâncer / Melanoma Limite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suíça